Published in J Exp Med on November 01, 1973
Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies. J Exp Med (1974) 2.02
Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice. J Exp Med (1975) 1.94
Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions. Proc Natl Acad Sci U S A (1979) 1.89
The murine immunoglobulin alpha gene expresses multiple transcripts from a unique membrane exon. EMBO J (1983) 1.34
Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins. Proc Natl Acad Sci U S A (1976) 1.27
Clonal nature of the immune response to phosphorylcholine (PC). V. Cross-idiotypic specificity among heavy chains of murine anti-PC antibodies and PC-binding myeloma proteins. J Exp Med (1975) 1.20
Subunit interactions in mouse myeloma proteins with anti-galactan activity. Proc Natl Acad Sci U S A (1976) 1.13
kappa Chain joining segments and structural diversity of antibody combining sites. Proc Natl Acad Sci U S A (1980) 1.13
Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype. J Exp Med (1975) 0.99
Human and murine phosphorycholine-binding immunoglobulins: conserved subgroup and first hypervariable region of heavy chains. Proc Natl Acad Sci U S A (1976) 0.93
A monoclonal antibody that defines an idiotope with two subsites in galactan-binding myeloma proteins. J Exp Med (1981) 0.89
History of Chemistry in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Bull Hist Chem (2014) 0.77
Chromic chloride: a coupling reagent for passive hemagglutination reactions. J Immunol (1967) 7.30
Quantitative procedures for use with the Edman-Begg sequenator. Partial sequences of two unusual immunoglobulin light chains, Rzf and Sac. Biochemistry (1971) 6.10
Variability in the lambda light chain sequences of mouse antibody. Nature (1970) 5.71
Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity. J Exp Med (1973) 4.93
Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol Rev (1972) 4.63
Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J Exp Med (1970) 4.49
Antigenic specificities related to the cold agglutinin activity of gamma M globulins. Science (1968) 4.32
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J Natl Cancer Inst (1972) 3.01
Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature (1962) 2.74
Advances in the gas chromatographic analysis of amino acid phenyl- and methylthiohydantoins. Anal Biochem (1972) 2.56
Antigen-binding myeloma proteins in mice. Ann N Y Acad Sci (1971) 2.33
Immunochemical analysis of the cross-reacting idiotypes of mouse myeloma proteins with anti-dextran activity and normal anti-dextran antibody. Proc Natl Acad Sci U S A (1973) 2.21
Three IgA myeloma immunoglobulins from the BALB/ mouse: precipitation with pneumococcal C polysaccharide. Science (1968) 2.20
Mouse immunoglobulin chains. A survey of the amino-terminal sequences of kappa chains. Biochemistry (1973) 1.85
Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature (1969) 1.82
Mouse immunoglobulin chains. Pattern of sequence variation among kappa chains with limited sequence differences. Biochemistry (1973) 1.75
Structure-function relationships among anti-gamma globulin antibodies. Ann N Y Acad Sci (1971) 1.71
Immunochemical studies of the reaction between a mouse myeloma macroglobulin and dextrans. Biochemistry (1970) 1.68
Light chain sequences of human IgM cold agglutinins (variable-region subgroups amino-acid sequence-kappa light chain-N-terminal). Proc Natl Acad Sci U S A (1972) 1.64
Mouse immunoglobulin chains. Partial amino acid sequence of a kappa chain. Biochemistry (1973) 1.54
Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins. Biochemistry (1973) 1.45
Experimental approaches to homogenous antibody populations. Mouse IgA myeloma proteins that bind polysaccharide antigens of enterobacterial origin. Fed Proc (1970) 1.29
Antigen-binding IgA myeloma proteins in mice: specificities to antigens containing -D 1 leads to 6 linked galactose side chains and a protein antigen in wheat. J Immunol (1972) 1.20
Localization of affinity-labeled residues on the heavy and light chain of two myeloma proteins with anti-hapten activity. Biochemistry (1972) 1.17
Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Sequence and position of a labeled tryptic peptide. Biochemistry (1970) 1.17
Reconstitution from subunits of the hapten binding sites and idiotypic determinants of mouse anti-phosphorylcholine myeloma proteins. J Immunol (1971) 1.15
On the location and structure of the active sites of antibody molecules. Proc Natl Acad Sci U S A (1968) 1.07
Affinity labeling by m-nitrobenzenediazonium fluoroborate of porcine ANTI-dinitrophenyl antibodies. Position of labeled tyrosine in the lambda-chains. Eur J Biochem (1971) 0.90
Hapten binding studies on mouse IgA myeloma proteins with antibody activity. J Immunol (1971) 0.86
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther (1999) 7.96
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10
Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry (1968) 4.83
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol (1996) 4.83
Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol Rev (1972) 4.63
Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J Exp Med (1970) 4.49
Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol (2001) 4.05
The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92
Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64
Antigen-binding myeloma proteins of mice. Adv Immunol (1977) 3.54
Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature (1988) 3.44
A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science (1986) 3.28
Evidence for the linkage of the IGC H locus to a gene controlling the idiotypic specificity of anti-p-azophenylarsonate antibodies in strain A mice. J Exp Med (1973) 3.18
Genetics of immunoglobulins in the mouse. Adv Immunol (1967) 3.14
Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis (1984) 3.10
Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J Natl Cancer Inst (1972) 3.01
Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 3.01
The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem (1988) 2.95
Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice. Science (1973) 2.94
Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas. Cell (1979) 2.92
Sequence and structure of Clp P, the proteolytic component of the ATP-dependent Clp protease of Escherichia coli. J Biol Chem (1990) 2.71
Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 2.59
Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol (1986) 2.57
DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science (1983) 2.40
Major urinary protein complex of normal mice: origin. Science (1965) 2.39
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36
Antigen-binding myeloma proteins in mice. Ann N Y Acad Sci (1971) 2.33
Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science (1984) 2.28
Three IgA myeloma immunoglobulins from the BALB/ mouse: precipitation with pneumococcal C polysaccharide. Science (1968) 2.20
Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1983) 2.16
Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines. Cell (1975) 2.13
VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules. EMBO J (1984) 1.98
IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins. J Immunol (1981) 1.97
The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution. Proteins (1986) 1.96
Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice. J Exp Med (1975) 1.94
Immunoglobulin structure: amino terminal sequences of mouse myeloma proteins that bind phosphorylcholine. Science (1974) 1.94
Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93
Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions. Proc Natl Acad Sci U S A (1979) 1.89
Mapping the antigenic epitope for a monoclonal antibody against lysozyme. J Immunol (1982) 1.87
Transplantation and preliminary characterisation of lymphocyte surface markers of Abelson virus-induced lymphomas. Nature (1975) 1.87
A BALB/c congenic strain of mice that carries a genetic locus (Ityr) controlling resistance to intracellular parasites. Infect Immun (1983) 1.86
Mouse immunoglobulin chains. A survey of the amino-terminal sequences of kappa chains. Biochemistry (1973) 1.85
Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth (2012) 1.84
Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature (1969) 1.82
Abelson virus-induced lymphomagenesis in mice. J Exp Med (1978) 1.81
Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination. Clin Chem (1981) 1.77
Mouse immunoglobulin chains. Pattern of sequence variation among kappa chains with limited sequence differences. Biochemistry (1973) 1.75
Structural studies on the major, capsular polysaccharide from Cryptococcus bacillisporus serotype B. Carbohydr Res (1980) 1.74
Mentally disordered homeless offenders--diversion from custody. Health Trends (1990) 1.74
Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J Immunol (1984) 1.69
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C. Immunochemistry (1978) 1.66
Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry (1976) 1.63
Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol (1981) 1.63
Idiotype of inulin-binding antibodies and myeloma proteins controlled by genes linked to the allotype locus of the mouse. J Immunol (1976) 1.62
Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61
Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol (1973) 1.60
Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A (1984) 1.59
Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome. Proc Natl Acad Sci U S A (1982) 1.58
Turtle-associated salmonellosis in the United States. Effect of Public Health Action, 1970 to 1976. JAMA (1980) 1.56
Crossing over between genes in the immunoglobulin heavy chain linkage group of the mouse. J Exp Med (1969) 1.56
Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol (1987) 1.55
Calcified pseudotumoural mediastinal amyloidosis. Thorax (1991) 1.55
Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J Anal Toxicol (1982) 1.54
Mouse immunoglobulin chains. Partial amino acid sequence of a kappa chain. Biochemistry (1973) 1.54
Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus. J Exp Med (1984) 1.52
Variations in the heavy polypeptide chain structure of gamma myeloma immunoglobulins from an inbred strain of mice and a hypothesis as to their origin. J Mol Biol (1965) 1.51
Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460. J Immunol (1969) 1.51
Mouse immunoglobulin D: construction and characterization of a cloned delta chain cDNA. Proc Natl Acad Sci U S A (1980) 1.50
Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med (1995) 1.49
Diversion from custody. I: Psychiatric assessment at the magistrates' court. Br J Psychiatry (1993) 1.49
Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A. Carbohydr Res (1981) 1.48
Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem (1981) 1.48
Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene. Infect Immun (1994) 1.47
Macroglobulin-Producing Plasma-Cell Tumor in Mice: Identification of a New Light Chain. Science (1965) 1.47
Isolation of type-C viruses from the Asian feral mouse Mus musculus molossinus. Int J Cancer (1975) 1.47
Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46
Gravitational microlensing by low-mass objects in the globular cluster M22. Nature (2001) 1.46
Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins. Biochemistry (1973) 1.45
Epidemiological investigation of risk factors for campylobacter colonization in Norwegian broiler flocks. Epidemiol Infect (1993) 1.43
In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol (1989) 1.41
The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D. Carbohydr Res (1979) 1.41
Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis (1988) 1.41
Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc Natl Acad Sci U S A (1982) 1.39
Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Hum Gene Ther (1998) 1.39